Sang Hoon Lee
founder and CEO
Biotechnology
ABL Bio
Singapore
Biography
Sang Hoon Lee is the founder and CEO of ABL Bio. Prior to creating ABL Bio, Sang Hoon Lee served as the head of the Bio Division at Hanwha Chemical from 2013 to 2016. He also was the co-founder and vice-president/CSO of PharmAbcine from 2009 to 2013. Sang Hoon Lee has strong entrepreneur and industry experience. He directed drug discovery and development at Exelixis, Genentech, AstraZeneca, and Chiron (now known as Novartis). Sang Hoon Lee received his B.A. and M.S. from the Seoul National University, his Ph.D. from The Ohio State University. He completed his postdoctoral fellow from Harvard Medical School and UCSF, and was a Scientist at Stanford Medical School.
Research Interest
Sang Hoon Lee is the founder and CEO of ABL Bio. Prior to creating ABL Bio, Sang Hoon Lee served as the head of the Bio Division at Hanwha Chemical from 2013 to 2016. He also was the co-founder and vice-president/CSO of PharmAbcine from 2009 to 2013. Sang Hoon Lee has strong entrepreneur and industry experience. He directed drug discovery and development at Exelixis, Genentech, AstraZeneca, and Chiron (now known as Novartis). Sang Hoon Lee received his B.A. and M.S. from the Seoul National University, his Ph.D. from The Ohio State University. He completed his postdoctoral fellow from Harvard Medical School and UCSF, and was a Scientist at Stanford Medical School.